Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir Gel Implementation in Family Planning Services
NCT01691768Phase 3Completed
- Sponsor
- CAPRISA
- Start
- Oct 2012
- Primary completion
- Apr 2015
- Modality
- Implantable Devices, Transdermal Patches, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir gel in human immunodeficiency virus infection (HIV), sponsored by CAPRISA. Started Oct 2012; status: completed.
02
Drugs
tenofovir gel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01691768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691768.